Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Aurobindo Pharma announces incorporation of subsidiary in Indonesia
The object of incorporation of this wholly owned step down subsidiary is to undertake manufacturing operations in Indonesia.
Nifty Pharma rallies 2%; Laurus, Ipca, Aurobindo, Torrent hit record highs
In the past month, the Nifty Pharma index outperformed the market by surging 7.4 per cent, as compared to 4.2 per cent rise in the Nifty 50.
Aurobindo Pharma’s investors await next leg of growth
Growth would be aided by the Pen-G project ramp-up, Lannett’s integration, new US product launches, expansion in Europe and contribution from higher-margin businesses
BSE 500 stocks: Adani Ports, Marico, Ather, Piramal Finance hit new highs
Adani Enterprises, Aurobindo Pharma, GMR Airports, Gujarat Flurochemicals, Oracle Financial Services and Star Health Insurance from BSE 500 stocks registered 52-week highs on Wednesday.
Aurobindo Pharma USA Inc. completes acquisition of Lannett
Aurobindo Pharma USA Inc., (APUSA), a wholly owned subsidiary of Aurobindo Pharma, announced the successful completion of its acquisition of Lannett Company, Inc., USA (Lannett), from Lannett Seller Holdco, Inc., following receipt of approval from the U.S. Federal Trade Commission on 18 June 2026.
Aurobindo Pharma among 9 mid-cap stocks to hit 52-week highs & rally up to 20% in a month
The Sensex fell 372 points on Monday, but nine BSE Midcap stocks touched fresh 52-week highs, signalling resilient investor confidence. Bank of Maharashtra, Thermax, Bharat Forge, Oracle Financial Services and Laurus Labs were among the key outperformers despite broader market weakness.
Aurobindo Pharma's API unit clears USFDA inspection with two observations
Aurobindo Pharma announced that the United States Food and Drug Administration (USFDA) had completed an inspection at its wholly owned subsidiary, Auroactive Pharma, located in Andhra Pradesh.
Aurobindo Pharma nears all-time high, up 30% in 4 months; more upside left?
Aurobindo Pharma stock hit a 52-week high at ₹1,585, and quoted close to its record high of ₹1,592 hit in September 2024. HDFC Securities maintains 'Add' rating on the stock.
Stock Alert: Aurobindo Pharma, Likhitha Infra, Vikran Engineering, Ashoka Buildcon, Bajaj Healthcare
Aurobindo Pharma announced that the United States Food and Drug Administration (USFDA) had completed an inspection at its wholly owned subsidiary, Auroactive Pharma, located in Andhra Pradesh.
Stocks to Watch today: HCL Tech, HDFC Bank, Turtlemint, Hexaware Tech, IRFC
Stocks to Watch today, June 29: Tata Motors PV, Torrent Power, Dr Reddy's Laboratories, Aurobindo Pharma, KEC International, and Adani Ports are among the top stocks to watch during today's trade
Nifty has more room to run; stay selective: Analysts
Indian stock markets are showing cautious optimism, with the Nifty eyeing the 24,300-25,000 zone amid ongoing volatility. Analysts recommend selective trading and specific strategies like a moderately bullish Call Spread. Top stock picks include TVS Motor, Samvardhana Motherson International, Oberoi Realty, Aurobindo Pharma, Vijaya Diagnostic Centre, and Mahindra & Mahindra Financial Services, each presenting unique buying opportunities with defined targets and stop losses.
Stocks to Watch for June 29: HDFC Bank, Kotak Mahindra Bank, Dr Reddy’s and more
After an extended weekend, Dalal Street returns to a packed corporate news flow. From IRFC's successful OFS and Power Grid's fundraising plans to fresh developments at HDFC Bank, KEC International, Aurobindo Pharma and Bajaj Healthcare, here are the stocks likely to remain in focus on Monday.